Overview

Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar Extraction

Status:
Completed
Trial end date:
2018-03-22
Target enrollment:
Participant gender:
Summary
This study evaluated a new drug fixed-dose combination tablet (FDC) called tramadol/diclofenac at two different strengths (fixed doses of 25 milligrams [mg] of tramadol and of diclofenac or of 50 mg each). Tramadol and diclofenac each relieve pain, but they do so by different mechanisms. They were used alone as comparator drug in this study. Both are marketed drugs and are standard treatment for acute pain, including wisdom tooth removal.
Phase:
Phase 3
Details
Lead Sponsor:
Grünenthal GmbH
Collaborators:
Grünenthal S.A.
Grünenthal, S.A.
Treatments:
Diclofenac
Tramadol